Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 7;12:203-211.
doi: 10.2147/TACG.S205335. eCollection 2019.

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents

Affiliations
Free PMC article

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents

Béatrice Dambaya et al. Appl Clin Genet. .
Free PMC article

Abstract

Background: Children show various degrees of vulnerability regarding HIV infection and disease progression. This disparity presents challenges for the follow-up of infected children. Here we investigated reasons behind this variability focusing on some host-related HIV genes.

Methods: We screened 570 Cameroonian children and adolescents, aged 1 to 19 years old. Among them, 137 were followed over 4 years, from 2010 to 2015. Upon signing a proxy consent, children and adolescents were classified according to their age, CD4 count, viral load and clinical symptoms as long-term non-progressors (LTNP), slow progressors (SP) and rapid progressors (RP). Their blood was collected every 6 months and used for biological and host genetic polymorphism analyses. Five genes were genotyped: Trim5α (R136Q), CCR5 promoter 59029G, CCR2-64I, SDF 3'A and CCR5-Δ32. Exposed non-infected (HEU) and unexposed HIV negative children (HNEU) were recruited as control groups.

Results: Among the 5 genes studied, the protective allele of Trim5α (R136Q) was present in all LTNP and in 72.34% and 2.56% of SP and RP, respectively (p<0.0001). The CCR5 promoter 59029G/G was also more present in LTNP and SP than in RP (p=0.02; p=0.04). The protective CCR2-64I homozygous genotype was almost absent in all groups, only the heterozygous genotype was present with a significant difference between RP vs SP (p=0.0001), and SP vs LTNP (p=0.0002). The CCR2-∆32 was completely absent either as homozygous or heterozygous genotype. It was a monomorphic allele. SDF 3'A was almost present as homozygous wild-type genotype in our study population and was associated neither to disease acquisition nor to disease progression.

Conclusion: Among the 5 genes described in the study, Trim 5α (R136Q), CCR5 promoter 59029G and CCR2V64I alleles were associated to the progression of HIV infection in children and adolescents.

Keywords: aids related genes; disease progression; infected children.

Conflict of interest statement

The authors report no conflicts of interest in this work.

Similar articles

See all similar articles

References

    1. Dollfus C, Le Chenadec J, Faye A, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010;51:214–224. doi:10.1086/652976 - DOI - PubMed
    1. Shah I, Nadiger M. Long term non progressors (LTNP) with vertically infected HIV children – a report from western India. Indian J Med Res. 2013;137:210–212. - PMC - PubMed
    1. O’Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36565–36574.
    1. Lederman MM, Penn-Nicholson A, Cho M. Mosier. Biology of CCR5 and its role in HIV infection and treatment. JAMA. 2006;296:815–826. doi:10.1001/jama.296.7.815 - DOI - PubMed
    1. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, et al. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS. 2003;17:1631–1638. doi:10.1097/00002030-200307250-00007 - DOI - PubMed

LinkOut - more resources

Feedback